An Update on Pulmonary Arterial Hypertension

被引:7
|
作者
Wapner, Joanna [1 ]
Matura, Lea Ann [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
来源
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2015年 / 11卷 / 05期
关键词
diagnosis; pathophysiology; pulmonary arterial hypertension; treatment; ORAL TREPROSTINIL; MANAGEMENT; DIAGNOSIS; THERAPY; DISEASE;
D O I
10.1016/j.nurpra.2015.02.004
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Pulmonary arterial hypertension (PAH) is a progressive disease that ultimately leads to right heart failure and death. PAH is defined as a mean pulmonary arterial pressure >= 25 mmHg with a pulmonary capillary wedge pressure <= 15 mmHg at rest. The diagnosis of PAH is one of exclusion; diagnostics include an extensive history, serology, chest radiograph, pulmonary function tests, ventilation/perfusion scan, transthoracic echocardiogram, and right heart catheterization. Treatment and care of patients with PAH can be complex. Therefore, the nurse practitioner is an integral member of the health care team caring for PAH patients, helping to ensure seamless care and support. (C) 2015 Elsevier, Inc. All rights reserved.
引用
收藏
页码:551 / 559
页数:9
相关论文
共 50 条
  • [31] Update in basic research in the therapy of pulmonary arterial hypertension
    Schermuly, R.
    Grimminger, F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (40) : S170 - S172
  • [32] Update on the pathomorphological assessment of vasculopathies in pulmonary arterial hypertension
    Dorfmüller, P
    Humbert, M
    Capron, F
    PATHOLOGE, 2006, 27 (02): : 140 - 146
  • [33] Investigational pharmacotherapy and immunotherapy of pulmonary arterial hypertension: An update
    Yang, Yicheng
    Lin, Fan
    Xiao, Zhiqiang
    Sun, Bo
    Wei, Zhiyao
    Liu, Bingyang
    Xue, Lin
    Xiong, Changming
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [34] An update on sildenafil in the treatment of pulmonary arterial hypertension in the neonate
    Schellack, Natalie
    Thom, Lorraine
    van Blerk, Zanli
    SA PHARMACEUTICAL JOURNAL, 2015, 82 (07) : 22 - 25
  • [35] Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
    Ramani, Gautam V.
    Park, Myung H.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 61 - 70
  • [36] Circulating biomarkers in pulmonary arterial hypertension: Update and future direction
    Pezzuto, Beatrice
    Badagliacca, Roberto
    Poscia, Roberto
    Ghio, Stefano
    D'Alto, Michele
    Vitulo, Patrizio
    Mule, Massimilano
    Albera, Carlo
    Volterrani, Maurizio
    Fedele, Francesco
    Vizza, Carmine Dario
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (03): : 282 - 305
  • [37] Update pulmonary arterial hypertension. Definitions, diagnosis, therapy
    Sommer, N.
    Richter, M. J.
    Tello, K.
    Grimminger, F.
    Seeger, W.
    Ghofrani, H. A.
    Gall, H.
    INTERNIST, 2017, 58 (09): : 937 - 957
  • [38] Update in systemic sclerosis-associated pulmonary arterial hypertension
    Gashouta, Mohamed A.
    Humbert, Marc
    Hassoun, Paul M.
    PRESSE MEDICALE, 2014, 43 (10): : E293 - E304
  • [39] Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update
    Wong, Alexandra K.
    Channick, Richard N.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2019, 11 : 71 - 85
  • [40] Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge
    Roldan, Tamara
    Landzberg, Michael J.
    Deicicchi, David J.
    Atay, Julie K.
    Waxman, Aaron B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (02): : 151 - 164